Skip to content

Post-Marketing Clinical Follow-Up of a Spine Implant

Post-Marketing Clinical Follow-up of an Anular Closure System (Barricaid®) to Confirm Comparability of Outcome Between Devices With Subcomponents From Two Different Suppliers

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03180749
Acronym
PMCFU
Enrollment
90
Registered
2017-06-08
Start date
2017-03-02
Completion date
2024-09-30
Last updated
2023-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Annular Tear of Lumbar Disc, Lumbar Disc Herniation

Brief summary

Post-Marketing Clinical Follow-up of an Anular Closure System (Barricaid®) to Confirm Comparability of Outcome between Devices with Subcomponents from Two Different Suppliers

Detailed description

Comparison of device integrity (anchor fracture and/or mesh detachment) and device movement/migration in patients implanted with the Barricaids with anchors from two different suppliers.

Interventions

OTHERFollow up per standard of care

Patients will come in 2 years post implantation and receive standard examinations

Sponsors

Intrinsic Therapeutics
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Each site will enroll all patients who were implanted with a Barricaid with an anchor manufactured by the second manufacturer. * Patients must be 18 years of age or older and able to understand and consent to participate in the study.

Exclusion criteria

* Not defined

Design outcomes

Primary

MeasureTime frameDescription
Device failures22+ months post implantationDevice failures and movement/migration will be assessed by a radiographic core laboratory.

Countries

Germany, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026